Joosten I - Search Results

1

Fine tuning of antigen-presenting cell-directed monoclonal antibody strategies in the induction of human allospecific T-cell tolerance in vitro.

Koenen HJ, Joosten I. Koenen HJ, et al. Among authors: joosten i. Transplant Proc. 1998 Aug;30(5):2447-9. doi: 10.1016/s0041-1345(98)00681-2. Transplant Proc. 1998. PMID: 9723532 No abstract available.

2

Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT.

van der Meer A, Allebes WA, Voorter CE, van den Berg-Loonen EM, Schattenberg AV, de Witte TJ, Joosten I. van der Meer A, et al. Among authors: joosten i. Bone Marrow Transplant. 1998 Dec;22(11):1049-55. doi: 10.1038/sj.bmt.1701489. Bone Marrow Transplant. 1998. PMID: 9877266

3

Natural killer cell reactivity and HLA-G in recurrent spontaneous abortion.

Emmer PM, Veerhoek M, Nelen WL, Steegers EA, Joosten I. Emmer PM, et al. Among authors: joosten i. Transplant Proc. 1999 Jun;31(4):1838-40. doi: 10.1016/s0041-1345(99)00182-7. Transplant Proc. 1999. PMID: 10371967 No abstract available.

4

Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness.

Koenen HJ, Joosten I. Koenen HJ, et al. Among authors: joosten i. Blood. 2000 May 15;95(10):3153-61. Blood. 2000. PMID: 10807782 Free article.

5

HLA-C mismatches induce strong cytotoxic T-cell reactivity in the presence of an additional DRB/DQB mismatch and affect NK cell-mediated alloreactivity.

van der Meer A, Allebes WA, Paardekooper J, Ruiter J, Joosten I. van der Meer A, et al. Among authors: joosten i. Transplantation. 2001 Sep 15;72(5):923-9. doi: 10.1097/00007890-200109150-00030. Transplantation. 2001. PMID: 11571460

6

Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.

Koenen HJ, Michielsen EC, Verstappen J, Fasse E, Joosten I. Koenen HJ, et al. Among authors: joosten i. Transplantation. 2003 May 15;75(9):1581-90. doi: 10.1097/01.TP.0000053752.87383.67. Transplantation. 2003. PMID: 12792519

7

IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression.

Koenen HJ, Fasse E, Joosten I. Koenen HJ, et al. Among authors: joosten i. J Immunol. 2003 Dec 15;171(12):6431-41. doi: 10.4049/jimmunol.171.12.6431. J Immunol. 2003. PMID: 14662842

8

A novel bispecific antihuman CD40/CD86 fusion protein with t-cell tolerizing potential.

Koenen HJ, den Hartog MT, Heerkens S, Fasse E, Ortiz-Buijsse A, van Neerven RJ, Simons PJ, Joosten I, Boon L. Koenen HJ, et al. Among authors: joosten i. Transplantation. 2004 Nov 27;78(10):1429-38. doi: 10.1097/01.tp.0000140481.41441.63. Transplantation. 2004. PMID: 15599306

9

Tolerizing effects of co-stimulation blockade rest on functional dominance of CD4+CD25+ regulatory T cells.

Coenen JJ, Koenen HJ, van Rijssen E, Hilbrands LB, Joosten I. Coenen JJ, et al. Among authors: joosten i. Transplantation. 2005 Jan 27;79(2):147-56. doi: 10.1097/01.tp.0000147460.93587.87. Transplantation. 2005. PMID: 15665762

10

CD27/CFSE-based ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells.

Koenen HJ, Fasse E, Joosten I. Koenen HJ, et al. Among authors: joosten i. J Immunol. 2005 Jun 15;174(12):7573-83. doi: 10.4049/jimmunol.174.12.7573. J Immunol. 2005. PMID: 15944257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters